"Sinopsis" puede pertenecer a otra edición de este libro.
"Sobre este título" puede pertenecer a otra edición de este libro.
Gastos de envío:
EUR 2,42
A Estados Unidos de America
Descripción Condición: New. Nº de ref. del artículo: 16675055-n
Descripción Soft Cover. Condición: new. Nº de ref. del artículo: 9780452298507
Descripción Condición: New. Brand New. Nº de ref. del artículo: 9780452298507
Descripción Paperback. Condición: new. Paperback. "Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years." - John Lescroart, New York Times bestselling author of DamageProcrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue-and still does. In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical companies, and the lies and inaccuracies concerning performance-enhancing drugs.Mark Duxbury was a J&J salesman who once believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J's business practices. He was fired and filed a whistleblower suit to warn the public.When Jan Schlichtman (A Civil Action) learned of Duxbury's crusade, he signed on. Now, he's fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life. ""Blood Feud" rivals "A Civil Action" for best non-fiction book of the past twenty years." -- John Lescroart, "New York Times" bestselling author of "Damage" Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue--and still does. In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical companies, and the lies and inaccuracies concerning performance-enhancing drugs. Mark Duxbury was a J&J salesman who once believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J's business practices. He was fired and filed a whistleblower suit to warn the public. When Jan Schlichtman ("A Civil Action") learned of Duxbury's crusade, he signed on. Now, he's fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9780452298507
Descripción Condición: New. pp. 448 1st Edition. Nº de ref. del artículo: 2642965624
Descripción Condición: New. pp. 448. Nº de ref. del artículo: 49816999
Descripción Condición: New. Buy with confidence! Book is in new, never-used condition 0.7. Nº de ref. del artículo: bk0452298504xvz189zvxnew
Descripción Paperback. Condición: new. New. Nº de ref. del artículo: Wizard0452298504
Descripción Paperback. Condición: new. New Copy. Customer Service Guaranteed. Nº de ref. del artículo: think0452298504
Descripción Condición: New. Nº de ref. del artículo: V9780452298507